Supplemental recommendations on adverse events following smallpox vaccine in the pre-event vaccination program: recommendations of the Advisory Committee on Immunization Practices
- PMID: 12729078
Supplemental recommendations on adverse events following smallpox vaccine in the pre-event vaccination program: recommendations of the Advisory Committee on Immunization Practices
Abstract
The Advisory Committee on Immunization Practices (ACIP) has issued recommendations previously for use of smallpox vaccine and supplemental recommendations for use of smallpox vaccine in the pre-event civilian vaccination program. On March 28, 2003, CDC reported cases of cardiac adverse events among persons vaccinated recently with smallpox vaccine. In response to these reports, ACIP held an emergency meeting on March 28 to make recommendations to CDC about medical screening of potential vaccinees and follow-up of persons with cardiovascular risk factors after vaccination. These recommendations supplement those previously issued by ACIP.
Similar articles
-
From the Centers for Disease Control and Prevention. Supplemental recommendations on adverse events following smallpox vaccine in the pre-event vaccination program: recommendations of the Advisory Committee on Immunization Practices.JAMA. 2003 Apr 23-30;289(16):2064. doi: 10.1001/jama.289.16.2064. JAMA. 2003. PMID: 12709453 No abstract available.
-
Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).MMWR Recomm Rep. 2003 Apr 4;52(RR-7):1-16. MMWR Recomm Rep. 2003. PMID: 12710832
-
Update: adverse events following smallpox vaccination--United States, 2003.MMWR Morb Mortal Wkly Rep. 2003 Apr 4;52(13):278-82. MMWR Morb Mortal Wkly Rep. 2003. PMID: 12729077
-
The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program.Vaccine. 2005 Mar 18;23(17-18):2078-81. doi: 10.1016/j.vaccine.2005.01.012. Vaccine. 2005. PMID: 15755574 Review.
-
Smallpox vaccination and myopericarditis: a clinical review.J Am Coll Cardiol. 2004 May 5;43(9):1503-10. doi: 10.1016/j.jacc.2003.11.053. J Am Coll Cardiol. 2004. PMID: 15120802 Review.
Cited by
-
Novel multi epitope-based vaccine against monkeypox virus: vaccinomic approach.Sci Rep. 2022 Sep 25;12(1):15983. doi: 10.1038/s41598-022-20397-z. Sci Rep. 2022. PMID: 36156077 Free PMC article.
-
Immunoinformatic-based design of immune-boosting multiepitope subunit vaccines against monkeypox virus and validation through molecular dynamics and immune simulation.Front Immunol. 2022 Oct 13;13:1042997. doi: 10.3389/fimmu.2022.1042997. eCollection 2022. Front Immunol. 2022. PMID: 36311718 Free PMC article.
-
Ischemic cardiac events and other adverse events following ACAM2000(®) smallpox vaccine in the Vaccine Adverse Event Reporting System.Vaccine. 2014 Aug 20;32(37):4758-65. doi: 10.1016/j.vaccine.2014.06.034. Epub 2014 Jun 18. Vaccine. 2014. PMID: 24951868 Free PMC article.
-
Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis.Vaccine. 2007 Apr 12;25(15):2913-8. doi: 10.1016/j.vaccine.2006.08.008. Epub 2006 Aug 22. Vaccine. 2007. PMID: 17067727 Free PMC article.
-
Drug and Anti-Viral Peptide Design to Inhibit the Monkeypox Virus by Restricting A36R Protein.Bioinform Biol Insights. 2022 Dec 19;16:11779322221141164. doi: 10.1177/11779322221141164. eCollection 2022. Bioinform Biol Insights. 2022. PMID: 36570327 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical